| Schedule of Share-based Compensation Expense |
The following table presents share-based compensation expense included in the accompanying condensed consolidated statements of operations and comprehensive (loss) income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
(In thousands) |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Cost of goods manufactured and sold |
|
$ |
1,834 |
|
|
$ |
1,621 |
|
|
$ |
5,519 |
|
|
$ |
4,882 |
|
Research and development |
|
|
6,953 |
|
|
|
6,435 |
|
|
|
23,640 |
|
|
|
18,836 |
|
Selling, general and administrative |
|
|
17,960 |
|
|
|
16,608 |
|
|
|
65,057 |
|
|
|
48,723 |
|
Share-based compensation expense |
|
|
26,747 |
|
|
|
24,664 |
|
|
|
94,216 |
|
|
|
72,441 |
|
Research and development |
|
|
— |
|
|
|
— |
|
|
|
5,940 |
|
|
|
— |
|
Selling, general and administrative |
|
|
— |
|
|
|
— |
|
|
|
12,468 |
|
|
|
— |
|
Share-based compensation expense for acceleration of Avadel Shares |
|
|
— |
|
|
|
— |
|
|
|
18,408 |
|
|
|
— |
|
Total share-based compensation expense |
|
$ |
26,747 |
|
|
$ |
24,664 |
|
|
$ |
112,624 |
|
|
$ |
72,441 |
|
|